5-Bromo-6-methoxy-1,3-dihydropyrrolo[2,3-b]pyridin-2-one, 98%, 250mg

(S)-4-(tert-Butyl)-2-(5,6,7,8-tetrahydroquinolin-2-yl)-4,5-dihydrooxazole, 97%, 100mg

2-(5-amino-3-methyl-1H-pyrazol-1-yl)-6-phenylpyrimidin-4(3H)-one, 95.0%, 250mg

Imidodicarbonic acid, 2-(3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-, 1,3-bis(1,1-dimethylethyl) ester, 97%, 1g

TERT-BUTYL (3-(2-HYDROXYETHOXY)PROPYL)CARBAMATE, 95%, 100mg

4',5'-Bis(4-aminophenyl)-[1,1':2',1''-terphenyl]-4,4''-diamine, 97%, 25g

9,10-Dioxo-9,10-dihydroanthracene-2-carboxylic acid, 95.0%, 5g

4-(Trans-4-butylcyclohexyl)phenol, 97.0%, 5g

1-Boc-3-Bromo-5-cyanoindole, 95.0%, 5g

E-plan EPL 20x/0.40 objective. Working distance 1.85 mm

Azepane-4-sulfonamide hydrochloride, 98%, 100mg

5,6,7,8-Tetrahydroquinolin-2(1H)-one, 95.0%, 100mg

(3,5-Dimethyl-isoxazol-4-yl)-acetic acid, 95.0%, 10g